The University of Wisconsin-Madison’s tech transfer office plans to invest $60 million in startups affiliated with the school over the next eight years and has launched a separate $50 million initiative aimed at commercializing UW-Madison research and discoveries in human therapeutics.

Erik Iverson, managing director of the Wisconsin Alumni Research Foundation—an independent organization that manages patents and licensing of intellectual property for UW-Madison—discussed those plans and more on Tuesday as he laid out a roadmap for WARF’s future during a presentation to university faculty members, Wisconsin business leaders, and others.

Iverson joined the organization in July 2016. He previously served as president of business and operations for the Infectious Disease Research Institute in Seattle. Iverson said that during his first year in the top job at WARF, he sought to “reset the strategy for the organization.” That involved encouraging those around him to “focus our energies on startups and entrepreneurship,” in addition to the intellectual property work WARF is most widely recognized for, he said.